CT 5002 An Open-Label, Non-Randomized, Monocentric Phase I Study Evaluating the Pharmacokinetic Profile of RhuDex [AV-1142742] Using a Tablet Formulation.
Phase of Trial: Phase I
Latest Information Update: 13 Dec 2018
At a glance
- Drugs AV 1142742 (Primary) ; Pantoprazole
- Indications Rheumatoid arthritis
- Focus Pharmacokinetics
- 26 Mar 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 19 Oct 2009 Status changed from suspended to recruiting, as reported in a MediGene media release.
- 14 Jul 2008 New trial record.